Stock under Consideration: Gilead Sciences Inc. (GILD)

Lloyd Doyle
April 17, 2018

The last session's volume was 4,038,833 compared to its average daily volume of 8.41M shares. The lower end of the projection is $1.48 per share, while the higher end is $1.82 per share. (NASDAQ:GILD) for 19,317 shs. It has underperformed by 11.55% the S&P500.

Nepsis Capital Management Inc increased its stake in Under Armour Inc (UA) by 96.87% based on its latest 2017Q4 regulatory filing with the SEC. To dig out factors, always good to learn who else owns shares, the institutional owner includes mutual funds and pension funds are major players.

The biopharmaceutical company reported $1.78 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.67 by $0.11. Arlington Capital Management Inc who had been investing in Coeur Mng Inc for a number of months, seems to be less bullish one the $1.61 billion market cap company. The stock decreased 1.39% or $0.105 during the last trading session, reaching $7.425. It has underperformed by 15.27% the S&P500. That's change of 0.23, from 2017Q3's 1.03. It turned negative, as 95 investors sold GILD shares while 545 reduced holdings. Altavista Wealth holds 3,511 shares. (NASDAQ:GILD) for 20,505 shs. Ariel Investments LLC owned 0.17% of Gilead Sciences worth $160,211,000 at the end of the most recent quarter. (NASDAQ:GILD)'s stock has performed 13.59%.

Among 39 analysts covering Under Armour (NYSE:UA), 8 have Buy rating, 10 Sell and 21 Hold. Wealthcare Advisory Partners LLC purchased a new stake in Gilead Sciences during the 3rd quarter worth $133,000. Ahl Ptnrs Limited Liability Partnership reported 114,529 shares or 0.13% of all its holdings. 58,523 are owned by Finemark Commercial Bank Tru. Union Financial Bank reported 0.07% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD)'s profitability or to compare the efficiency of different investments, hence, GILD return on investment (ROI) is 19.90%. Steinberg Global Asset Mgmt owns 12,653 shares for 0.13% of their portfolio. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Two analysts have rated the stock with a sell rating, nine have given a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company. Therefore 21% are positive. Gilead Sciences had 126 analyst reports since July 29, 2015 according to SRatingsIntel. Finally, Sandy Spring Bank grew its stake in shares of Gilead Sciences by 5.2% during the 3rd quarter. (NASDAQ:GILD) on Wednesday, February 7 with "Buy" rating. Waters Parkerson & Co Ltd Liability Company owns 4,210 shares for 0.03% of their portfolio. Gilead Sciences now has an average rating of "Buy" and an average price target of $88.61. The stock has "Hold" rating by Jefferies on Friday, October 27. The company rating was maintained by Credit Suisse on Wednesday, January 3. The rating was maintained by Cowen & Co on Tuesday, July 25 with "Buy".

In related news, EVP James R. Meyers sold 100,000 shares of the business's stock in a transaction dated Tuesday, January 16th. $3.68 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) for 17,000 shares. $4.68 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) for 12,948 shares.

Gilead Sciences, Inc. discovers, develops, and commercializes medicines in the areas of unmet medical needs in Europe, North America, Asia, South America, Africa, Australia, India, and the Middle East. (NASDAQ:GILD) for 232,086 shares. They expect $1.59 EPS, down 27.73% or $0.61 from last year's $2.2 per share. The company has a market cap of $98,075.59, a PE ratio of 8.79, a PEG ratio of -1.73 and a beta of 1.18.


Gilead Sciences (NASDAQ:GILD) last posted its quarterly earnings data on Tuesday, February 6th.

Investors sentiment increased to 1.37 in 2017 Q4. Its up 0.14, from 0.88 in 2017Q3. 141 funds opened positions while 592 raised stakes. Pnc Fincl Ser Grp Inc invested in 548,002 shares. Meiji Yasuda Life Commerce has 93,709 shares for 0.68% of their portfolio.

Since October 30, 2017, it had 1 insider buy, and 5 selling transactions for $322,487 activity. Twin Mngmt holds 0.34% or 97,720 shs in its capital. Canada Pension Plan Board invested 0.01% of its portfolio in Coeur Mining, Inc. X Mgmt Co Ltd Co has invested 0.44% in Coeur Mining, Inc. (NYSE:VZ) for 335,424 shares. Bessemer Gp Incorporated holds 0.01% or 40,033 shs. Healthinvest Prtnrs stated it has 36,100 shares or 5.46% of all its holdings. Hap Trading Limited Liability stated it has 42,943 shares. Clark Estates Ny, a New York-based fund reported 689,282 shares. Domini Impact Invs Lc reported 5.9% stake. The New Jersey-based Prudential Financial Inc has invested 0% in Coeur Mining, Inc. (NYSE:CDE) on Wednesday, June 14 with "Buy" rating.

Among 29 analysts covering Verizon Communications Inc. The stock has "Hold" rating by Oppenheimer on Thursday, December 21. Therefore 34% are positive. (NYSE:UA) on Friday, December 18 with "Buy" rating. The firm has "Hold" rating given on Wednesday, February 1 by Canaccord Genuity. The rating was upgraded by Morgan Stanley to "Overweight" on Tuesday, April 4. BMO Capital Markets maintained the stock with "Hold" rating in Monday, August 28 report. The rating was downgraded by Needham on Tuesday, July 26 to "Hold". Robert W. Baird maintained it with "Hold" rating and $52.0 target in Wednesday, January 24 report. After a recent look, the stock's first resistance level is 75.75. The stock of Coeur Mining, Inc. Leerink Swann has "Market Perform" rating and $83 target.

Trading volume is a gauge of how many times a stock is bought and sold in a given time period (most commonly, within a day of trading, known as the average daily trading volume - ADTV).

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER